Teradyne Memory Test Sales Jump 110% to $128M in Q3
Teradyne’s third-quarter memory test sales rose 110% sequentially to $128 million, driven by AI-related HBM and DRAM demand. This strong segment performance offset a weak broader memory market and reinforces the company’s semiconductor test equipment growth thesis.
1. Share Performance Underwhelms Against Broader Market
Teradyne shares retreated by 1.2% in the latest session, even as the broader market advanced modestly. This marks the second consecutive day of weakness, bringing the six-month return to a flat-to-negative pattern. Trading volume jumped 25% above its 30-day average, suggesting heightened investor attention. The pullback follows a series of upgrades from boutique research houses that have emphasized Teradyne’s AI-driven growth opportunities.
2. Q4 Fiscal 2025 Guidance Highlights Cyclical Risks and Valuation Stretch
Management forecasts Q4 revenue in a range of $920 million to $1.0 billion, with GAAP EPS expected between $1.12 and $1.39. While the midpoint implies year-over-year growth of roughly 10%, analysts warn that this guidance underscores the company’s sensitivity to semiconductor capital spending cycles. At a current enterprise-value to adjusted EBITDA multiple near 57x, Teradyne trades at a steep premium to the peer group average of 22x, leaving limited margin for error if end-market demand softens.
3. Memory Test Sales Accelerate on AI-Driven Demand
Teradyne reported $128 million in memory test segment revenue for the third quarter, up 110% sequentially and accounting for nearly 15% of total revenue. Strong uptake of high-bandwidth memory test solutions for AI applications more than offset a subdued general memory market. Orders in this segment climbed 85% quarter-over-quarter, reflecting early commitments from cloud and hyperscale customers deploying next-generation processors.
4. Analysts Maintain Cautious Optimism Amid Secular Growth Themes
Despite valuation concerns, seven out of ten analysts maintain a Buy rating, citing long-term catalysts such as industrial reshoring and robotics automation. One independent research firm reiterated its $283 per-share target, highlighting the secular shift toward AI-powered manufacturing and the structural advantage of Teradyne’s high-end test portfolio. However, most advisories recommend a dollar-cost-averaging approach given the imminent earnings release and the potential for volatility around guidance execution.